Report Detail

Pharma & Healthcare Global Animal Blood Plasma Products and Derivatives Market Insights, Forecast to 2025

  • RnM3518353
  • |
  • 12 June, 2019
  • |
  • Global
  • |
  • 118 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Animal blood is one of the main by-products of animal slaughtering and processing. It has rich protein content and high nutritional value. Plasma protein, as an important protein material, can be used for animal feed and food processing. Studies have shown that plasma proteins are enzymatically treated to obtain hydrolysates consisting of small peptides and amino acids, which are more easily digested and absorbed by the body. At the same time, they show antioxidant properties, inhibition of angiotensin converting enzyme activity, attenuation, and other functional properties and can be used as potential nutrients. Supplements, food additives, and nutraceuticals.
Plasma protein is the most important solid component in plasma, and its amino acid content is rich and its nutritional value is high. At present, it is mainly processed into plasma protein powder as livestock feed or nutritional supplement, or as a raw material or additive for various food systems [11]. Studies have shown that plasma proteins are hydrolyzed by specific enzymes to produce hydrolysates consisting of small peptides and amino acids, which are more easily digested and absorbed by the human body. At the same time, they show antioxidation, inhibition of angiotensin-converting enzyme (ACE) and attenuation. The functional properties of peptides isolated from them have been widely studied as potential nutritional supplements, food additives and nutraceuticals.
The global Animal Blood Plasma Products and Derivatives market is valued at 1030 million US$ in 2018 and will reach 1880 million US$ by the end of 2025, growing at a CAGR of 7.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Animal Blood Plasma Products and Derivatives market based on company, product type, end user and key regions.

This report studies the global market size of Animal Blood Plasma Products and Derivatives in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Animal Blood Plasma Products and Derivatives in these regions.
This research report categorizes the global Animal Blood Plasma Products and Derivatives market by top players/brands, region, type and end user. This report also studies the global Animal Blood Plasma Products and Derivatives market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Lake Immunogenics
Auckland BioSciences
Kraeber & Co. GmbH
Sigma-Aldrich
Thermo Fisher Scientific
Rocky Mountain Biologicals
LAMPIRE Biological Laboratories
Bovogen Biologicals
Proliant
ANZCO Foods

Market size by Product
Immunoglobulin
Fibrinogen
Serum Albumin
Fetal Bovine Serum
Market size by End User
Cell Culture Media
Food Industry
Pharmaceutical Industry
Sports Nutrition
Nutrition Supplements
Cosmetic Industry
Diagnostic Industry
Pet Food Industry

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Animal Blood Plasma Products and Derivatives market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Animal Blood Plasma Products and Derivatives market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Animal Blood Plasma Products and Derivatives companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Animal Blood Plasma Products and Derivatives submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Animal Blood Plasma Products and Derivatives are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Animal Blood Plasma Products and Derivatives market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Animal Blood Plasma Products and Derivatives Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Animal Blood Plasma Products and Derivatives Market Size Growth Rate by Product
      • 1.4.2 Immunoglobulin
      • 1.4.3 Fibrinogen
      • 1.4.4 Serum Albumin
      • 1.4.5 Fetal Bovine Serum
    • 1.5 Market by End User
      • 1.5.1 Global Animal Blood Plasma Products and Derivatives Market Size Growth Rate by End User
      • 1.5.2 Cell Culture Media
      • 1.5.3 Food Industry
      • 1.5.4 Pharmaceutical Industry
      • 1.5.5 Sports Nutrition
      • 1.5.6 Nutrition Supplements
      • 1.5.7 Cosmetic Industry
      • 1.5.8 Diagnostic Industry
      • 1.5.9 Pet Food Industry
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Animal Blood Plasma Products and Derivatives Market Size
      • 2.1.1 Global Animal Blood Plasma Products and Derivatives Revenue 2014-2025
      • 2.1.2 Global Animal Blood Plasma Products and Derivatives Sales 2014-2025
    • 2.2 Animal Blood Plasma Products and Derivatives Growth Rate by Regions
      • 2.2.1 Global Animal Blood Plasma Products and Derivatives Sales by Regions
      • 2.2.2 Global Animal Blood Plasma Products and Derivatives Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Animal Blood Plasma Products and Derivatives Sales by Manufacturers
      • 3.1.1 Animal Blood Plasma Products and Derivatives Sales by Manufacturers
      • 3.1.2 Animal Blood Plasma Products and Derivatives Sales Market Share by Manufacturers
      • 3.1.3 Global Animal Blood Plasma Products and Derivatives Market Concentration Ratio (CR5 and HHI)
    • 3.2 Animal Blood Plasma Products and Derivatives Revenue by Manufacturers
      • 3.2.1 Animal Blood Plasma Products and Derivatives Revenue by Manufacturers (2014-2019)
      • 3.2.2 Animal Blood Plasma Products and Derivatives Revenue Share by Manufacturers (2014-2019)
    • 3.3 Animal Blood Plasma Products and Derivatives Price by Manufacturers
    • 3.4 Animal Blood Plasma Products and Derivatives Manufacturing Base Distribution, Product Types
      • 3.4.1 Animal Blood Plasma Products and Derivatives Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Animal Blood Plasma Products and Derivatives Product Type
      • 3.4.3 Date of International Manufacturers Enter into Animal Blood Plasma Products and Derivatives Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Animal Blood Plasma Products and Derivatives Sales by Product
    • 4.2 Global Animal Blood Plasma Products and Derivatives Revenue by Product
    • 4.3 Animal Blood Plasma Products and Derivatives Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Animal Blood Plasma Products and Derivatives Breakdown Data by End User

    6 North America

    • 6.1 North America Animal Blood Plasma Products and Derivatives by Countries
      • 6.1.1 North America Animal Blood Plasma Products and Derivatives Sales by Countries
      • 6.1.2 North America Animal Blood Plasma Products and Derivatives Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Animal Blood Plasma Products and Derivatives by Product
    • 6.3 North America Animal Blood Plasma Products and Derivatives by End User

    7 Europe

    • 7.1 Europe Animal Blood Plasma Products and Derivatives by Countries
      • 7.1.1 Europe Animal Blood Plasma Products and Derivatives Sales by Countries
      • 7.1.2 Europe Animal Blood Plasma Products and Derivatives Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Animal Blood Plasma Products and Derivatives by Product
    • 7.3 Europe Animal Blood Plasma Products and Derivatives by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Animal Blood Plasma Products and Derivatives by Countries
      • 8.1.1 Asia Pacific Animal Blood Plasma Products and Derivatives Sales by Countries
      • 8.1.2 Asia Pacific Animal Blood Plasma Products and Derivatives Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Animal Blood Plasma Products and Derivatives by Product
    • 8.3 Asia Pacific Animal Blood Plasma Products and Derivatives by End User

    9 Central & South America

    • 9.1 Central & South America Animal Blood Plasma Products and Derivatives by Countries
      • 9.1.1 Central & South America Animal Blood Plasma Products and Derivatives Sales by Countries
      • 9.1.2 Central & South America Animal Blood Plasma Products and Derivatives Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Animal Blood Plasma Products and Derivatives by Product
    • 9.3 Central & South America Animal Blood Plasma Products and Derivatives by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Animal Blood Plasma Products and Derivatives by Countries
      • 10.1.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales by Countries
      • 10.1.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Animal Blood Plasma Products and Derivatives by Product
    • 10.3 Middle East and Africa Animal Blood Plasma Products and Derivatives by End User

    11 Company Profiles

    • 11.1 Lake Immunogenics
      • 11.1.1 Lake Immunogenics Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Lake Immunogenics Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Lake Immunogenics Animal Blood Plasma Products and Derivatives Products Offered
      • 11.1.5 Lake Immunogenics Recent Development
    • 11.2 Auckland BioSciences
      • 11.2.1 Auckland BioSciences Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Auckland BioSciences Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Auckland BioSciences Animal Blood Plasma Products and Derivatives Products Offered
      • 11.2.5 Auckland BioSciences Recent Development
    • 11.3 Kraeber & Co. GmbH
      • 11.3.1 Kraeber & Co. GmbH Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Products Offered
      • 11.3.5 Kraeber & Co. GmbH Recent Development
    • 11.4 Sigma-Aldrich
      • 11.4.1 Sigma-Aldrich Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Products Offered
      • 11.4.5 Sigma-Aldrich Recent Development
    • 11.5 Thermo Fisher Scientific
      • 11.5.1 Thermo Fisher Scientific Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Products Offered
      • 11.5.5 Thermo Fisher Scientific Recent Development
    • 11.6 Rocky Mountain Biologicals
      • 11.6.1 Rocky Mountain Biologicals Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Products Offered
      • 11.6.5 Rocky Mountain Biologicals Recent Development
    • 11.7 LAMPIRE Biological Laboratories
      • 11.7.1 LAMPIRE Biological Laboratories Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Products Offered
      • 11.7.5 LAMPIRE Biological Laboratories Recent Development
    • 11.8 Bovogen Biologicals
      • 11.8.1 Bovogen Biologicals Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Products Offered
      • 11.8.5 Bovogen Biologicals Recent Development
    • 11.9 Proliant
      • 11.9.1 Proliant Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Proliant Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Proliant Animal Blood Plasma Products and Derivatives Products Offered
      • 11.9.5 Proliant Recent Development
    • 11.10 ANZCO Foods
      • 11.10.1 ANZCO Foods Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 ANZCO Foods Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 ANZCO Foods Animal Blood Plasma Products and Derivatives Products Offered
      • 11.10.5 ANZCO Foods Recent Development

    12 Future Forecast

    • 12.1 Animal Blood Plasma Products and Derivatives Market Forecast by Regions
      • 12.1.1 Global Animal Blood Plasma Products and Derivatives Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Animal Blood Plasma Products and Derivatives Revenue Forecast by Regions 2019-2025
    • 12.2 Animal Blood Plasma Products and Derivatives Market Forecast by Product
      • 12.2.1 Global Animal Blood Plasma Products and Derivatives Sales Forecast by Product 2019-2025
      • 12.2.2 Global Animal Blood Plasma Products and Derivatives Revenue Forecast by Product 2019-2025
    • 12.3 Animal Blood Plasma Products and Derivatives Market Forecast by End User
    • 12.4 North America Animal Blood Plasma Products and Derivatives Forecast
    • 12.5 Europe Animal Blood Plasma Products and Derivatives Forecast
    • 12.6 Asia Pacific Animal Blood Plasma Products and Derivatives Forecast
    • 12.7 Central & South America Animal Blood Plasma Products and Derivatives Forecast
    • 12.8 Middle East and Africa Animal Blood Plasma Products and Derivatives Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Animal Blood Plasma Products and Derivatives Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Animal Blood Plasma Products and Derivatives . Industry analysis & Market Report on Animal Blood Plasma Products and Derivatives is a syndicated market report, published as Global Animal Blood Plasma Products and Derivatives Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Animal Blood Plasma Products and Derivatives market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,053.70
      4,580.55
      6,107.40
      3,584.10
      5,376.15
      7,168.20
      604,422.00
      906,633.00
      1,208,844.00
      325,767.00
      488,650.50
      651,534.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report